共 50 条
- [41] TELOMERE SHORTENING AND AML PROGRESSION IN PATIENTS WITH MYELODYSPLASTIC SYNDROME AND DELETION 5Q TREATED WITH LENALIDOMIDEHAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 378 - 379Goehring, G.Lange, K.Hofmann, W.Buesche, G.Kreipe, H.Hellstroem-Lindberg, E.Giagounidis, A.Schlegelberger, B.
- [42] Real-world Data From the Swiss Lenalidomide in MDS del(5q) (SLIM)-Registry Identify New Chances and Challenges in Lenalidomide Treatment of Patients With MDS del(5q)HEMASPHERE, 2022, 6 (07):Rufer, AxelAngermann, HubertBenz, RudolfBonadies, NicolasCalderoni, AntonelloCantoni, NathanEfthymiou, AnnaEscher, RobertFavre, GenevieveFriess, DorotheaGschwend, AndreasHimmelmann, AndreasHolbro, AndreasKeller, PeterKouroupi, EiriniLehmann, ThomasPedarnig, NikolausRigamonti, VeroniqueSamii, KavehSchmidt, AdrianSchafer, Hans-PeterSperb, RolandStussi, GeorgWinkler, AnnetteZenhausern, ReinhardGoede, Jeroen S.
- [43] Lenalidomide in the myelodysplastic syndrome with chromosome 5q deletionNEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (14): : 1456 - 1465List, AlanDewald, GordonBennett, JohnGiagounidis, AristotleRaza, AzraFeldman, EricPowell, BayardGreenberg, PeterThomas, DeborahStone, RichardReeder, CraigWride, KentonPatin, JohnSchmidt, MicheleZeldis, JeromeKnight, Robert
- [44] Telomere dynamics in patients with del (5q) MDS before and under treatment with lenalidomideLEUKEMIA RESEARCH, 2015, 39 (11) : 1292 - 1298Beier, FabianKharabi Masouleh, BehzadBuesche, GuntramVentura Ferreira, Monica S.Schneider, Rebekka K.Ziegler, PatrickWilop, StefanVankann, LuciaGattermann, NorbertPlatzbecker, UweGiagounidis, AristotelesGoetze, Katharina S.Nolte, FlorianHofmann, Wolf-KarstenHaase, DetlefKreipe, HansPanse, JensBlasco, Maria A.Germing, UlrichBruemmendorf, Tim H.
- [45] Lenalidomide in del 5q MDS: Responses and side effects revisitedLEUKEMIA RESEARCH, 2011, 35 (11) : 1440 - 1441Tiu, Ramon V.Sekeres, Mikkael A.
- [46] IMPACT OF 5Q BREAKPOINTS ON CLINICAL OUTCOMES IN PATIENTS WITH IPSS LOW-/INT-1-RISK MYELODYSPLASTIC SYNDROMES (MDS) AND ISOLATED DEL(5Q) TREATED WITH LENALIDOMIDE IN THE MDS-004 STUDYHAEMATOLOGICA, 2013, 98 : 80 - 80Gohring, G.Giagounidis, A.List, A.Hellstrom-Lindberg, E.Sekeres, M.Mufti, G.Schlegelbergerl, B.Morrill, J.Wu, C.Skikne, B.Fenaux, P.
- [47] Efficacy of lenalidomide for treatment of anemia in secondary myelodysplastic syndrome (MDS) with chromosome 5q deletionBLOOD, 2007, 110 (11) : 226B - 226BMintzer, David MichaelBillet, Shira N.
- [48] Unusual clonal evolution involving 5q in a case of myelodysplastic syndrome with deletion 5q 31 treated with lenalidomideHAEMATOLOGICA, 2008, 93 (02) : 315 - 316Eclache, VirginieDa Rocha, AnnaLe Roux, GenevieveFenaux, Pierre
- [49] MOLECULAR MECHANISMS OF LENALIDOMIDE RESISTANCE IN DEL(5Q) MYELODYSPLASTIC SYNDROMESEXPERIMENTAL HEMATOLOGY, 2020, 88 : S72 - S72Martinez-Hoyer, SergioDeng, YuParker, JeremyJiang, JihongDocking, RoderickMo, AngelaGharaee, NadiaJadersten, MartinKulasekararaj, AustinMalcovati, LucaList, AlanHellstrom-Lindberg, EvaPlatzbecker, UweKarsan, Aly